Traders should now look for long-biased trades in CPRT as long as it's trending above today's low of $32.20, and then once it sustains a move or close above its 50-day at $33.43 with volume that hits near or above 943,897 shares. If that breakout hits soon, then CPRT will set up to re-test or possibly take out its next major overhead resistance level at $35 to $36.50.
Babcock & Wilcox
Babcock & Wilcox
(BWC - Get Report)
is a technology innovator in power generation systems, a specialty constructor of nuclear components and a service provider in its segments. This stock is trading up 1.4% at $27.91 in recent trading.
Today's Volume: 670,000
Average Volume: 692,785
Volume % Change: 64%
From a technical perspective, BWC is bouncing higher here right above some near-term support at $27.17 with decent upside volume. This move is quickly pushing shares of BWC within range of triggering a near-term breakout trade. That trade will hit once BWC manages to take out some near-term overhand resistance at $28.02 with high volume. At last check, BWC has hit an intraday high of $28.09 and the volume is closing in on surpassing its three-month average action of 692,785 shares.
Traders should now look for long-biased trades in BWC as long as it's trending above some key near-term support at $27.17 or above its 50-day at $26.46, and then once it sustains a move or close above $28.02 with volume that hits near or above 692,785 shares. If that breakout triggers soon, then BWC will set up to re-test or possibly take out its next major overhead resistance level at its 52-week high of $29.97. Any high-volume move above $29.97 will then put $32 o $33.87 into range for shares of BWC.
is a global skin health company providing integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers. This stock is trading up 3.6% at $15.59 in recent trading.
Today's Volume: 492,000
Average Volume: 133,632
Volume % Change: 541%
Shares of PHMD are moving higher here after the company said it moved to a profit in the fourth quarter after it acquired Radiancy Inc. PhotoMedex earnings $5.9 million, or 27 cents per share, in the quarter ended in December. A year earlier, it took a loss of $3 million, or 22 cents per share. Revenue soared 91% to $54.8 million from $28.7 million.